<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01105013</url>
  </required_header>
  <id_info>
    <org_study_id>TEU-TOL-03/09</org_study_id>
    <nct_id>NCT01105013</nct_id>
  </id_info>
  <brief_title>Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections</brief_title>
  <acronym>Tonaftato</acronym>
  <official_title>Study Clinical, Multicenter, Phase III, to Evaluate the Efficacy and Safety of Tolnaftate Cream in the Treatment of Patients With Fungal Infections Like Tinea Foot, Tinea and Tinea Crural Body&quot;</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Laboratório Teuto Brasileiro S/A</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Laboratório Teuto Brasileiro S/A</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a study clinical, multicenter, Phase III trial, to evaluate the efficacy and safety
      of tolnaftate cream in the treatment of patients with fungal infections such as Tinea foot,
      Tinea and Tinea crural body.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Clinical, multicenter, Phase III, to evaluate the efficacy and safety of 10mg/g
      tolnaftate cream in the treatment of patients with fungal infections such as Tinea foot,
      Tinea and Tinea crural body.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">July 2012</completion_date>
  <primary_completion_date type="Anticipated">July 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the efficacy and safety of the tolnaftate cream 10 mg / g.</measure>
    <time_frame>97 days</time_frame>
    <description>Apply the product in sufficient quantity to cover the affected area 2 times daily (every 12 hours) for 60 days.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Fungal Infections</condition>
  <condition>Tinea Pedis</condition>
  <condition>Tinea Cruris</condition>
  <condition>Tinea Corporis</condition>
  <arm_group>
    <arm_group_label>tonaftato</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Apply the product in sufficient quantity to cover the affected area 2 times daily (every 12 hours) for 60 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clotrimazole</intervention_name>
    <description>Apply the product in sufficient quantity to cover the affected area 2 times daily (every 12 hours) for 60 days.</description>
    <arm_group_label>tonaftato</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients of both sexes, of any race, aged 12 years;

          -  Ability to understand and sign the IC (for patients older than age) in the case of
             minors monitoring and consent of a guardian;

          -  Clinical diagnosis of fungal infections for tinea pedis (ringworm of the feet) or
             tinea cruris (ringworm of the groin region), or tinea corporis (ringworm in other body
             areas);

          -  Direct mycological exam positive for fungi;

        Exclusion Criteria:

          -  Pregnant women or nursing mothers;

          -  Use of topical or oral antifungal;

          -  Use of steroids;

          -  Allergy or hypersensitivity to any component of product;

          -  Clinical cases of tinea infection by bacteria and / or eczema, tinea extensive and
             onychomycosis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dagoberto Brandão</last_name>
    <role>Study Director</role>
    <affiliation>PHC - Pharma Consulting</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Machado Filho, investigator</last_name>
    <phone>55 11 99018981</phone>
    <email>dermatologia@fmabc.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Monice Karolis, coordinator</last_name>
    <phone>55 11 97963572</phone>
    <email>monicekarolis@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Faculdade de Medicina do ABC</name>
      <address>
        <city>Santo André</city>
        <state>São Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Dr. Carlos Machado</last_name>
    </contact>
    <contact_backup>
      <last_name>Monice Karolis</last_name>
    </contact_backup>
    <investigator>
      <last_name>Dr. Carlos Machado</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dra. Andréa Gerbase</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dra. Denise Steiner</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>April 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2010</study_first_submitted>
  <study_first_submitted_qc>April 15, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 16, 2010</study_first_posted>
  <last_update_submitted>April 11, 2012</last_update_submitted>
  <last_update_submitted_qc>April 11, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>fungal infections</keyword>
  <keyword>tinea</keyword>
  <keyword>tonaftato</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Mycoses</mesh_term>
    <mesh_term>Tinea</mesh_term>
    <mesh_term>Tinea Pedis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tolnaftate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

